Therapygenetics: Moving towards personalized psychotherapy treatment

Trends in Cognitive Sciences

Volumn 16, Issue 1, 2012, Pages 11-12

  Beevers, Christopher G ^a   McGeary, John E ^b,c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COGNITIVE BEHAVIOR; GENETIC VARIATION;

GENES;

BEHAVIORAL RESEARCH;

ANTIDEPRESSANT AGENT; SEROTONIN TRANSPORTER;

ANXIETY DISORDER; CHILD; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; COST EFFECTIVENESS ANALYSIS; GENE DOSAGE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HUMAN; NEUROBIOLOGY; PEDIATRIC ANXIETY DISORDER; PERSONALIZED MEDICINE; PHARMACOGENETICS; PROMOTER REGION; PSYCHOTHERAPY; SHORT SURVEY; SOCIAL PSYCHOLOGY; TREATMENT RESPONSE;

EID: 84855337261     PISSN: 13646613     EISSN: 1879307X     Source Type: Journal    
DOI: 10.1016/j.tics.2011.11.004     Document Type: Short Survey

References (10)

1. Eley T.C., et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol. Psychiatry 2011, 10.1038/mp.2011.132.
2. Caspi A., et al. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 2010, 167:509-527.
3. Belsky J., Pluess M. Beyond diathesis stress: differential susceptibility to environmental influences. Psychol. Bull. 2009, 135:885-908.
4. Beevers C.G., et al. Association of the serotonin transporter gene promoter region (5-HTTLPR) polymorphism with biased attention for emotional stimuli. J. Abnorm. Psychol. 2009, 118:670-681.
5. Amir N., et al. Attention training in individuals with generalized social phobia: A randomized controlled trial. J. Consult. Clin. Psychol. 2009, 77:961-973.
6. Fox E., et al. The serotonin transporter gene alters sensitivity to attention bias modification: evidence for a plasticity gene. Biol. Psychiatry 2011, 70:1049-1054.
7. De Jager P.L., et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol. 2009, 8:1111-1119.
8. Siegle G.J., et al. Neurobehavioral therapies in the 21st century: Summary of an emerging field and an extended example of cognitive control training for depression. Cogn. Ther. Res. 2007, 31:235-262.
9. Otto M.W., et al. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol. Psychiatry 2010, 67:365-370.
10. Sturm R., Wells K.B. How can care for depression become more cost-effective?. JAMA 1995, 273:51-58.